Company intelligence / Profile preview

Wuhan Ruier Biotechnology

Wuhan, Hubei, Chinapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

Wuhan Ruier Biotechnology specializes in the production of moist wound care products using pure natural materials. The company is positioned as a manufacturer with a focus on high-quality, natural-based medical dressings for various types of wounds. No clinical trial data is referenced; their products are commercialized medical devices rather than drugs requiring clinical trials.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Wuhan Ruier Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Ruier Biotechnology.

Explore the full profile